<HashMap><database>bioimages</database><scores/><additional><omics_type>Unknown</omics_type><submitter>María Verónica Baez</submitter><journal>The Journal of Cell Biology</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-JCBD-201108159</full_dataset_link><attach_to>JCB</attach_to><legend>Smaug 1 (green) foci associate with Synapsin clusters (red) in the adult rat hippocampus. 60% of synapses of the CA3 region contain S-foci. A rabbit polyclonal anti-Smaug1 serum (Baez and Boccaccio, JBC, 2005) was used. Tubulin is depicted in blue.</legend><legend>Primary hippocampal neurons were treated with a non-targeting siRNA. Synapsin is shown in green, and tubulin BIII is in blue.</legend><legend>Smaug1 ECFP colocalizes with PBs in U2OS cells. The PB markers Dcp1a (red) and Hedls (blue) were immunostained. Most Smaug1-foci (S-foci) colocalize or are in close contact with P-bodies. Smaug1-ECFP is depicted in green.</legend><legend>Smaug 1 knockdown affects synapse size and number. Two out of four sequences against rat Samug 1 (siSmaug1c and siSmaug1 d) elicit the effect. The treatment with siSmaug1b (no effect) is shown. Synapsin is shown in green, and tubulin BIII is in blue.</legend><legend>Primary hippocampal neurons were exposed to a 60-min NMDA pulse. Protein synthesis was evaluated in situ before and after the pulse with the Click It reagents HPG (green) or AHA (red), respectively, using the FUNCAT strategy.</legend><legend>Smaug1 ECFP colocalizes with P-bodies in U2OS cells. The PB markers Dcp1a (red) and Rck/p54 (blue) were immunostained. Most Smaug1-foci (S-foci) colocalize or are in close contact with P-bodies. Smaug1-ECFP is depicted in green.</legend><legend>Primary neurons were treated with siRNA against the P-body component Rck/p54 and the P-bodies visualized by staining of Rck/p54 (green). Map2 is depicted in green. A significant reduction in P-bodies is observed.</legend><legend>Smaug 1 (green) forms foci in the somatodendritic compartment of the adult rat hippocampus (CA1 region). A rabbit polyclonal anti-human Smaug1 serum (Baez and Boccaccio, JBC, 2005) was used. Tubulin is depicted in blue.</legend><legend>Primary neurons were treated with a non-targeting RNA and the P-bodies visualized by staining of Rck/p54 (green). Map2 is depicted in green.</legend><legend>Smaug 1 knockdown affects synapse size and number. Two out of four sequences against rat Samug 1 (siSmaug1c and siSmaug1 d) elicit the effect. The treatment with siSmaug1d (no effect) is shown. Synapsin is shown in green, and tubulin BIII is in blue.</legend><legend>Smaug 1 knockdown affects synapse size and number. Two out of four sequences against rat Samug 1 (siSmaug1c and siSmaug1 d) elicit the effect. The treatment with siSmaug1c (no effect) is shown. Synapsin is shown in green, and tubulin BIII is in blue.</legend><legend>Background staining of a preimmune rabbit serum (green) was assessd in the CA3 region of the adult rat brain. Tubulin is depicted in blue. Synapsin is in red.&lt;br /></legend><legend>Background staining of a preimmune rabbit serum (green) was assessd in the somatodendritic compartment of the adult rat hippocampus (CA1 region). Tubulin is depicted in blue. Synapsin is in red.&lt;br /></legend><legend>Smaug 1 knockdown affects synapse size and number. Two out of four sequences against rat Samug 1 (siSmaug1c and siSmaug1 d) elicit the effect. The treatment with siSmaug1a (no effect) is shown. Synapsin is shown in green, and tubulin BIII is in blue.</legend><repository>bioimages</repository><figure_sub>Figure 3 - D</figure_sub><figure_sub>Figure 8 - C</figure_sub><figure_sub>Image 131266 (Figure 2 - A)</figure_sub><figure_sub>Image 131282 (Figure 3 - D)</figure_sub><figure_sub>Image 131300 (Figure 9 - C)</figure_sub><figure_sub>Image 131298 (Figure 9 - C)</figure_sub><figure_sub>Image 131272 (Figure 2 - B)</figure_sub><figure_sub>Image 131279 (Figure 3 - D)</figure_sub><figure_sub>Image 131270 (Figure 2 - B)</figure_sub><figure_sub>Image 131295 (Figure 8 - C)</figure_sub><figure_sub>Image 131296 (Figure 9 - C)</figure_sub><figure_sub>Figure 9 - C</figure_sub><figure_sub>Figure 9</figure_sub><figure_sub>Figure 8</figure_sub><figure_sub>Image 131267 (Figure 2 - A)</figure_sub><figure_sub>Image 131280 (Figure 3 - D)</figure_sub><figure_sub>Image 131271 (Figure 2 - B)</figure_sub><figure_sub>Image 131281 (Figure 3 - D)</figure_sub><figure_sub>Image 131299 (Figure 9 - C)</figure_sub><figure_sub>Image 131297 (Figure 9 - C)</figure_sub><figure_sub>Figure 2 - A</figure_sub><figure_sub>Figure 3</figure_sub><figure_sub>Figure 2</figure_sub><figure_sub>Figure 2 - B</figure_sub><pubmed_authors>Graciela Lidia Boccaccio</pubmed_authors><pubmed_authors>María Verónica Baez</pubmed_authors><pubmed_authors>Luciana Luchelli</pubmed_authors><pubmed_authors>Malena Pascual</pubmed_authors><pubmed_authors>Darío Maschi</pubmed_authors><pubmed_authors>Martín Habif</pubmed_authors><pubmed_authors>María Gabriela Thomas</pubmed_authors></additional><is_claimable>false</is_claimable><name>Smaug1 mRNA-silencing foci respond to NMDA and modulate synapse formation</name><description/><dates><release>2011-12-26T11:22:28Z</release><modification>2018-11-29T11:22:28Z</modification><creation>2018-11-29T11:22:28Z</creation></dates><accession>S-JCBD-201108159</accession><cross_references><doi>10.1083/jcb.201108159</doi></cross_references></HashMap>